{"id":"testosterone-t-gel-1-62","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Application site reactions (erythema, pruritus)"},{"rate":"5-10","effect":"Acne"},{"rate":"1-5","effect":"Polycythemia"},{"rate":"1-3","effect":"Gynecomastia"},{"rate":"2-5","effect":"Headache"},{"rate":"1-3","effect":"Mood changes/irritability"}]},"_chembl":{"chemblId":"CHEMBL1200335","moleculeType":"Small molecule","molecularWeight":"400.60"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Testosterone is a naturally occurring androgen that binds to androgen receptors throughout the body to promote development and maintenance of male sexual characteristics, muscle mass, bone density, and other physiological functions. The 1.62% gel formulation allows for transdermal delivery, providing steady-state testosterone levels with once-daily application. This replacement therapy restores testosterone to normal physiological ranges in men with clinically low testosterone (hypogonadism).","oneSentence":"Testosterone gel delivers exogenous testosterone through transdermal absorption to replace deficient endogenous testosterone in hypogonadal men.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:38:08.568Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Testosterone replacement therapy in adult males with hypogonadism"}]},"trialDetails":[{"nctId":"NCT02432261","phase":"PHASE1","title":"Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men","status":"COMPLETED","sponsor":"Kimberly Myer","startDate":"2015-04","conditions":"Healthy","enrollment":44},{"nctId":"NCT03198728","phase":"PHASE3","title":"Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men","status":"COMPLETED","sponsor":"Marius Pharmaceuticals","startDate":"2017-07-05","conditions":"Hypogonadism, Male","enrollment":314},{"nctId":"NCT04274894","phase":"PHASE4","title":"A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism","status":"COMPLETED","sponsor":"AbbVie","startDate":"2020-05-12","conditions":"Hypogonadism","enrollment":246},{"nctId":"NCT01686828","phase":"PHASE1, PHASE2","title":"T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin","status":"COMPLETED","sponsor":"University of Washington","startDate":"2013-06","conditions":"Insulin Resistance, Type 2 Diabetes Mellitus, Obesity","enrollment":53},{"nctId":"NCT01130298","phase":"PHASE1","title":"An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier","status":"COMPLETED","sponsor":"AbbVie","startDate":"2010-05","conditions":"Healthy","enrollment":24},{"nctId":"NCT02081300","phase":"PHASE3","title":"Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism","status":"COMPLETED","sponsor":"Lipocine Inc.","startDate":"2014-02","conditions":"Male Hypogonadism","enrollment":315},{"nctId":"NCT02317640","phase":"PHASE1, PHASE2","title":"TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males","status":"UNKNOWN","sponsor":"Kessler Foundation","startDate":"2017-03-15","conditions":"Spinal Cord Injury","enrollment":56},{"nctId":"NCT00433199","phase":"PHASE3","title":"Testosterone Treatment for Hypogonadal Men","status":"COMPLETED","sponsor":"Abbott","startDate":"2007-02","conditions":"Hypogonadism","enrollment":274}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Testosterone (T) Gel 1.62%","genericName":"Testosterone (T) Gel 1.62%","companyName":"Abbott","companyId":"abbott","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Testosterone gel delivers exogenous testosterone through transdermal absorption to replace deficient endogenous testosterone in hypogonadal men. Used for Testosterone replacement therapy in adult males with hypogonadism.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}